NA Molecular Diagnostics Services Market - Industry Trends and Forecast to 2030
North America molecular diagnostics services market is projected to register a substantial CAGR of 8.0% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation
Global Molecular Diagnostics Services Market, By Service Type (Instrument Repair Services, Training Services, Compliance Services, Calibration Services, Maintenance Services, Scalable Automation Services, Turnkey Services, Instrument Relocation Services, Hardware Customization, Performance Assurance Services, Design and Development Services, Supply Chain Solutions, New Product Introduction Services, Manufacturing Services, Environmental & Regulatory Services, Medical Management Systems Certification & Auditing, Clinical Research Services, Consultative Services, and Other Services), Technology (PCR, Real Time PCR, Next Generation Sequencing, and Other Technologies), End User (Hospitals, Diagnostic Centers, Academic & Research Institutions, and Others), Country (U.S., Canada, and Mexico) Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the North America molecular diagnostics services market are:
• Technological developments and enhancement in instrumentation
• Strategic initiatives by market players
Market Players
The key market players operating in the North America molecular diagnostics services market are listed below:
• F. Hoffmann-La Roche Ltd
• Danaher
• BIOMERIEUX
• QIAGEN
• Thermo Fisher Scientific
• Bio-Rad Laboratories, Inc
• Abbott
• DiaSorin S.p.A
• Hologic, Inc
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook